US budget cash for stem cells
This article was originally published in Clinica
The National Institutes of Health (NIH) has money set aside in its 2003 fiscal budget that will be used to administer the award of federal research dollars for embryonic stem cell research, Health and Human Services Secretary Tommy Thompson told reporters last week. But Mr Thompson said he could not say how much has been allocated. The NIH said in mid-January that it is currently awarding reviewing applications for additional funds for stem cell research from researcher's with existing grants and expects to award new research project grants in July.
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.